Year Authors/Creators Item Type Full Text

Article

Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy. (2022) Fecht, Daniela; Chadeau-Hyam, Marc; Owen, Ruth; Gregson, John; Halliday, Brian P; Lota, Amrit S; Gulliver, John; Ware, James S; Pennell, Dudley J; Kelly, Frank J; Shah, Anoop SV; Miller, Mark R; Newby, David E; Prasad, Sanjay K; Tayal, Upasana

Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death. (2010) Holland, Richard; Rechel, Boika; Stepien, Karolina; Harvey, Ian; Brooksby, Iain

Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial. (2023) Khan, Muhammad Shahzeb; Anker, Stefan D; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Januzzi, James L; Chopra, Vijay K; Piña, Ileana L; Böhm, Michael; Ponikowski, Piotr; Verma, Subodh; Brueckmann, Martina; Vedin, Ola; Peil, Barbara; Zannad, Faiez; Packer, Milton; Butler, Javed

Cracking the NNT Code: Effect of Ivabradine on Recurrent Hospitalizations. (2015) Rogers, Jennifer K; Kielhorn, Adrian; Borer, Jeffrey S; Ford, Ian; Pocock, Stuart J

Hospitalized heart failure: rates and long-term mortality. (2004) Shahar, Eyal; Lee, Seungmin; Kim, Joseph; Duval, Sue; Barber, Cheryl; Luepker, Russell V

Conference or Workshop Item

Study design of a mortality trial with intravenous levosimendan - the SURVIVE study - in patients with acutely decompensated heart failure. (2004) Mebazaa, A; Cohen-Solal, A; Kleber, F; Nieminen, MS; Packer, M; Pocock, S; Poder, P; Sarapohja, T; Kivikko, M